<?xml version="1.0" encoding="UTF-8"?><rss xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:atom="http://www.w3.org/2005/Atom" version="2.0" xmlns:cc="http://cyber.law.harvard.edu/rss/creativeCommonsRssModule.html">
    <channel>
        <title><![CDATA[Stories by Emily Anne on Medium]]></title>
        <description><![CDATA[Stories by Emily Anne on Medium]]></description>
        <link>https://medium.com/@emilyanne_13043?source=rss-c1fd7d9dfc53------2</link>
        <image>
            <url>https://cdn-images-1.medium.com/fit/c/150/150/1*CaNs7yCJ3EpScCdZZ2nvJA.jpeg</url>
            <title>Stories by Emily Anne on Medium</title>
            <link>https://medium.com/@emilyanne_13043?source=rss-c1fd7d9dfc53------2</link>
        </image>
        <generator>Medium</generator>
        <lastBuildDate>Mon, 16 Nov 2026 01:40:50 GMT</lastBuildDate>
        <atom:link href="https://medium.com/@emilyanne_13043/feed" rel="self" type="application/rss+xml"/>
        <webMaster><![CDATA[yourfriends@medium.com]]></webMaster>
        <atom:link href="http://medium.superfeedr.com/" rel="hub"/>
        <item>
            <title><![CDATA[Ethics in Pharmaceutical Marketing]]></title>
            <link>https://medium.com/@emilyanne_13043/mind-over-marketing-in-pharmaceutical-companies-190e32191e41?source=rss-c1fd7d9dfc53------2</link>
            <guid isPermaLink="false">https://medium.com/p/190e32191e41</guid>
            <category><![CDATA[healthcare]]></category>
            <category><![CDATA[corruption]]></category>
            <category><![CDATA[pharmaceuticals-industry]]></category>
            <category><![CDATA[marketing]]></category>
            <category><![CDATA[medicine]]></category>
            <dc:creator><![CDATA[Emily Anne]]></dc:creator>
            <pubDate>Wed, 14 Mar 2018 19:36:07 GMT</pubDate>
            <atom:updated>2018-03-14T21:08:01.129Z</atom:updated>
            <content:encoded><![CDATA[<p>Since medication has become extremely profitable, the growing desire for companies’ financial expansion has fueled the use of inappropriate tactics for marketing to the public. This desire has begun to trump companies&#39; responsibility to remain ethical in their marketing and influence on medical opinion. Corruption in business is common, and the pharmaceutical industry is still a business at its roots. Although many companies claim they put the patients first, there is conflict of interest between maximizing profit and maintaining the safety of patients by remaining transparent on the adverse effects of medications. A lack of transparency hinders physicians and other healthcare workers to make informed choices and puts patients at risk.</p><p>Marketing tactics used by many companies affects what our doctors prescribe us. Companies will hire medical workers (usually physicians and researchers) to give promotional talks on the benefits of medications. Having someone educated rather than a representative of the company gives the medicine more legitimacy, thus more doctors are likely to prescribe it to their patients. These hired medical workers, or “Key Opinion Leaders” are paid and sent in to put a positive light on the medicine under discussion, and most say they personally support their claims. However, that’s easy to say when the pharmaceutical company is providing these talkers with a 100,000$ salary. Who’s to say that they truly support these medications or if they are merely bribed into it?</p><p>Companies also provide physicians with luncheons, gifts and invitations to conferences in remote areas. At some of these conferences, attending healthcare workers can earn points for furthering their education. However, the information provided at these conferences can be warped or influenced by the company representative speaking. Many representatives working for pharmaceutical companies are taught communication methods to manipulate and sell more of the company’s product. Exposure to these tactics affects medical opinion and what our doctors prescribe us.</p><p>Patients are constantly at risk at being inappropriately prescribed medications. In many cases, medication advertisements shown to the public focus on the benefits while omitting adverse side effects, making them seem safer than they are. Diseases and illnesses are manufactured through these advertisements, promoting pills for natural conditions such as cosmetic issues or trivial ailments, ultimately creating a over-medicated society.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/390/1*iSg5B0HpU9-bjjnTfvl1tA.jpeg" /><figcaption>Credit: Community Ethics Network</figcaption></figure><p>These commercials also have the capacity to directly change behavior in regards to treating illness. “One study found that although 19% of Direct To Consumer ads mentioned lifestyle changes as an adjunct to medication, none mentioned them as an alternative to drug treatment. By promoting a drug as the solution to a health problem, these advertisements may lead viewers to believe that adopting healthy behaviors, such as a good diet and exercise, are ineffective or unnecessary” (1) This causes viewers to believe that medication is the only answer to their problems.</p><p>The United States and New Zealand are the only countries who allow Direct to Consumer advertisements. Although the Federal Drug Administration monitors advertisements, action against violators in recent years have fallen off dramatically. This either means the industry is starting to comply, or most likely there is a decline in FDA oversight. The industry is constantly growing but the number of FDA workers has stayed the same, making it difficult to keep tabs on each company. In a study conducted by UCLA (2), advertisements in medical journals were found to lack references, information on the populations tested on, and insufficient summaries of the side effects. Many advertisements on TV tend to exaggerate the benefits of a medication, then quickly glean over the negatives with a summary of negatives at the end.</p><p>It is frightening to think these companies who influence the lives of millions are losing their ability to remain ethical. With so much influenced by the interests of private pharmaceutical business, it’s difficult to imagine what medicine would be like if improving patient health was the only priority of companies.</p><p>Works Cited</p><p>1.C. Lee Ventola, “Direct-to-Consumer Pharmaceutical Advertising; Therapeutic or Toxic?”, P&amp;T, Vol 36, №100, October 2011, PP. 669–684</p><p>2. Kusserow, Richard, “Prescription Drug Advertisements in Medical Journals” Office of Inspector General, 1992, pp 1–36</p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=190e32191e41" width="1" height="1" alt="">]]></content:encoded>
        </item>
    </channel>
</rss>